17 followers
Meet Calpacizumab (Cablivi™): The first nanobody-based therapy approved for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood-clotting disorder associated with an over-production of the von Willebrand factor. https://t.co/U